Cerebrospinal Fluid Proteomics Distinguishes Stages of Alzheimer’s Disease Continuum
Researchers quantified 2,492 cerebrospinal fluid proteins using tandem-mass-tag mass spectrometry to map stage-specific molecular changes across the Alzheimer's disease continuum.

